The company is significantly advanced this development of an novel therapy for ATTR-CM, utilizing the compound. Early patient data reveals significant improvements for individuals diagnosed with a debilitating illness. https://attrcm156470.blogsumer.com/40971325/bridgebio-advances-amyloidosis-treatment-with-attruby